Europe


Open Source or Commercial? Lasse Goerlitz, CLC Bio, Talks Bioinformatics

Podcast brought to you by: Ingenuity Variant Analysis - Identify causal variants from human sequencing data in just hours.

Guests:

Lasse Goerlitz, VP of Communications, CLC Bio
Bio and Contact Info

Listen (5:16) Highest demand coming from agro

Listen (3:06) What is holding back the adoption of genomic medicine?

Listen (4:03) A commercial platform with plug-ins

Listen (3:37) Open source vs commercial software

Listen (4:40) The all-in-one guys

Listen (5:56) Genomics in Europe

The repeating trend from industry to industry is for software to go from fragmented, custom applications toward larger dominant platforms. It's still the early days for bioinformatics, and just who the dominant platforms of the future will be remain unknown. Will they be open source, public platforms or commercial platforms?

CLC Bio, a bioinformatics company has been working on the solution for eight years now and hopes that their platform which works with many different plug-ins will become number one for biologists around the world. In today's show, CLC's VP of Communications, Lasse Goerlitz, talks about their platform and trends in genomics. Currently their heaviest users are in ag bio, but the demand from the clinic is rising. We conclude with a discussion of differences between Europe and the US in the genomics space.

Bringing Bio Together with Europe, in Europe: BPFE 2012 with Robert Kilpatrick

Podcast brought to you by: Assay Depot - the world's largest cloud-based Research Exchange for pharmaceutical research services.

Guests:

Dr. Robert Lee Kilpatrick, Co-founder of TVG Bio and Contact Info

Chapters: (Advance the marker)

0:45 History and outlook of Biopartnering Future Europe (BPFE)

6:45 Face to face meetings still the number one way to get business done

13:11 Path to TVG

18:05 Biotech only interesting if it enhances life on earth

TVG Network, based in Santa Cruz, CA, has been producing the longest running bio partnering conference in Europe. This year, with the encouragement of the European Commission, the show has been renamed "Biopartnering Future Europe (BPFE)" to reference the Commission's goal of creating a knowledge-based economy in Europe. The show has also been moved this year from London to the more centrally located Brussels, Belgium, capital of the European Union. It takes place October 7-9, 2013.

Robert previews the show and explains why biotech companies want to participate. He says that "face to face meetings are still the number one way to get business done."

Joining Robert in his home garden, we ask him about his journey from history of science teacher in Cambridge, England to producing global conferences from Santa Cruz, CA.

BlueSEQ's Michael Heltzen

Podcast Sponsor: DNAnexus- Unlocking the potential of DNA-based medicine and biotechnology with a collaborative and scalable DNA data management and analysis technology platform.

Guest:

Michael Heltzen, CEO, BlueSEQ Bio and Contact Info

Listen (2:26) Why BlueSEQ?

Listen (5:20) How does the service work?

Listen (3:53) Platform agnostic

Listen (1:47) Who are the providers?

Listen (2:35) Thoughts on Roche action

Listen (2:22) Will you add bioinformatics?

Listen (1:54) Being an entrepreneur

Listen (5:03) Bio in Denmark

To wrap up our series on Sequencing and Genomic Medicine, we’d like to welcome Michael Heltzen. He’s the founder and CEO of BlueSEQ, a new start-up based in Arhus Denmark, serving as an online sequencing exchange, matching providers and researchers. Michael has served as Director of Partner Sales at CLC Bio, a bioinformatics company also based in Denmark and as VP at BGI Europe. Michael is a board member of both Startup City Denmark and the Copenhagenomics Foundation.



New to Mendelspod?

We advance life science research, connecting people and ideas.
Register here to receive our newsletter.

or skip signup